$TMS

Teamshares Inc.: Teamshares Reports 2Q 2026 Results and Reaffirms 2026 Outlook

Teamshares (NASDAQ:TMS) reported 2Q 2026 revenue of $148.7 million, up 20% year over year, and net income of $9.5 million. Adjusted EBITDA rose to $9.6 million. The company reaffirmed 2026 Pro Forma Adjusted EBITDA guidance of $60 million and said it has LOIs for 10 acquisitions targeting about $30 million annual EBITDA.

Original reporting
Published Aug 14, 2026, 11:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 12:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TMS
Bullish
medium confidence
Mentioned
$TMS
Relevance
8/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$TMSBullishMed
01

Why it matters

The release combines a quarterly performance update with a reaffirmed full-year EBITDA target and a quantified acquisition pipeline under LOIs, alongside concrete capital actions (debt repayments) and a proposed warehouse facility to fund future closings.

02

Market read

Traders can reassess execution risk and funding runway using the LOI pipeline size, the reaffirmed 2026 EBITDA target, and the status of warehouse-facility refinancing.

03

What to watch

The proposed warehouse facility and refinancing process are still subject to definitive documentation and customary conditions, which could delay acquisition closings and pressure near-term execution.

Relevance 8/10Novelty 8/10Timing: pre-market today, ahead of the Aug 14 8:30 a.m. ET conference call

Background

Teamshares began trading on Nasdaq on June 23, 2026 after a significant equity raise tied to its business combination, and it uses acquisition financing as the core input to its programmatic SME buy-and-build model.

Company-level read

Ticker impact

$TMSBullishMedium confidence
Context

Teamshares reported 2Q results and reaffirmed 2026 Pro Forma Adjusted EBITDA guidance of $60M, plus LOIs for 10 acquisitions totaling ~$30M annual EBITDA.

Expected impact

Moderately positive bias, with upside if investors view the LOI-to-close conversion and warehouse-facility refinancing as de-risking acquisition funding.

Evidence & confidence

The article provides fresh, decision-relevant datapoints: quarterly financials, reaffirmed full-year guidance, LOI pipeline size, and new proposed senior secured warehouse facility plus debt repayments.

Market effects

Reinforces the market narrative that tech-enabled acquirers can scale via public-market capital and warehouse financing, potentially supporting peer sentiment.

No specific regional read-through beyond US-listed small-cap growth/financing appetite.

Limited, as the disclosure is company-specific and US-focused.

Counterpoint

LOIs are non-binding and the $30M annual EBITDA under LOI may not translate into closed deals, so the reaffirmed $60M target could be at risk if financing terms or diligence outcomes worsen.

Key entities

  • Teamshares

    Tech-enabled acquiror of SMEs, reporting 2Q 2026 results and reaffirming 2026 Pro Forma Adjusted EBITDA guidance.

  • Live Oak Acquisition Corp. V

    Referenced as part of the business combination that provided gross proceeds and enabled debt repayment and growth funding.

  • SME Segment

    Primary operating segment where revenue and EBITDA growth were driven by acquisitions and some organic growth.

Related articles

$TMSMed

Teamshares Inc (TMS): Results of Operations and Financial Condition

Teamshares Inc (TMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 teamshares-20260630xq2earn.htm EX-99.1 Document Teamshares Reports 2Q 2026 Results and Reaffirms 2026 Outlook New York, NY – August 14, 2026 – Teamshares (NASDAQ:TMS, the “Company”), a tech-enabled acquiror of high-quality SMEs, announced financial results for the secon

$PRHIMed

Presurance Holdings, Inc. (PRHI): Results of Operations and Financial Condition

Presurance Holdings, Inc. (PRHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prhi-ex99_1.htm EX-99.1 EX-99.1 News Release For Further Information: Jessica Gulis, 248.509.9202 ir@prehld.com Presurance Holdings Reports 2026 Second Quarter Financial Results Troy, MI, August 12, 2026 – Presurance Holdings, Inc. (Nasdaq: PRHI) (“Presurance” or the “C

$BRUNMed

Boost Run Inc. (BRUN): Results of Operations and Financial Condition

Boost Run Inc. (BRUN) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0002090646 0002090646 2026-08-14 2026-08-14 0002090646 BRUN:ClassCommonStock0.0001ParValueMember 2026-08-14 2026-08-14 0002090646 BRUN:WarrantsEachWholeWarrantIsExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2026-08-14 2026-08-14 iso4217:USD xb

$MYSZMedAI 8/10

My Size Inc.: MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale

MySize, Inc. (NASDAQ: MYSZ) reported Q2 2026 revenue of $3.07 million, up 53% year over year, and $5.46 million for the first half, up 57%. Percentil revenue rose to $413,000. Gross margin fell to about 31.7% as commerce mix increased. Net loss was $1.75 million. Cash used in operations was $1.97 million for six months.

$OMERMed

Omeros Corporation Q2 2026 Earnings Call Summary

Omeros reported Q2 2026 progress for Yartemlia, citing 188% quarter-over-quarter net sales growth and $4.1 million positive operating cash flow. Management said adult transplant centers now drive about 75% of sales and formulary approval is 55% to 60%. It also discussed cash flow positivity by mid-2027, repurchases, and regulatory items including a July 1 J-code and Oct. 1 NTAP.

$AMATMed

Applied Materials shares are down on elevated expectations. Here's why analysts say it's time to buy.

Applied Materials (AMAT) shares fell more than 5% in premarket after it reported results Thursday. The company posted revenue of $9.1B, up 25% year over year and above FactSet’s $8.99B consensus, and EPS of $3.50 vs $3.40. Guidance and gross-margin pressure from higher capex were cited. JPMorgan raised its price target to $660; KeyBanc and Jefferies also reiterated targets.